Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion

Hyeon Gyu Seo1, Han Byeol Kim1,2, Ji Young Yoon2

  • 1Glycosylation Network Research Center, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.

Cell Death & Disease
|September 30, 2020
PubMed

Insights

X-linked inhibitor of apoptosis (XIAP) targets O-GlcNAc transferase (OGT) for degradation, suppressing colon cancer growth. O-GlcNAcylation of XIAP by OGT is crucial for this process, revealing a novel regulatory mechanism.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • O-GlcNAc transferase (OGT) is crucial for modifying proteins and is highly expressed in cancers.
  • Mechanisms controlling OGT expression in cancer remain unclear.

Purpose of the Study:

  • To elucidate the regulatory mechanism of OGT in colon cancer cells.
  • To investigate the role of X-linked inhibitor of apoptosis (XIAP) in OGT regulation.

Main Methods:

  • Investigated OGT as a substrate of the E3 ubiquitin ligase XIAP.
  • Identified XIAP as the primary E3 ligase for OGT in colon cancer.
  • Examined the reciprocal regulation between OGT and XIAP.

Main Results:

  • OGT modifies XIAP at serine 406, enhancing XIAP's E3 ligase activity towards OGT.
  • XIAP-mediated OGT degradation suppresses colon cancer cell growth and invasion.
  • Demonstrated a novel reciprocal regulatory loop between OGT and XIAP.

Conclusions:

  • XIAP is the key E3 ubiquitin ligase for OGT in colon cancer.
  • O-GlcNAcylation of XIAP by OGT is essential for OGT degradation and tumor suppression.
  • This reciprocal regulation offers a new therapeutic target for controlling cancer progression.